Congratulations to our 2020 AIBN Graduates
Dr Aini Syahida Mat Yassim, Marcellin Group
Improved Virus and Protein Yields Using Insect Cell Technology: Genetically Engineered Insect Cell Lines Stably Expressing Anti-Apoptotic and Anti RNAi Genes
Dr Amir H Farokh Niaei, Bernhardt Group
Enhancement of the performance of rechargeable batteries by proposing new materials
Dr Guangze Yang, Zhao Group
Core-Shell Nanomaterials for Drug Delivery and Controlled Release
Dr Jianye Fu, Yu Group
Synthesis and characterization of novel silica nanoparticles for delivery applications
Ms Jing Geng, Yu Group
Study on the lyophilization process of silica nanoparticle-based DNA formulations
Dr Jing Wang, Trau Group
Engineering Surface-Enhanced Raman Scattering Strategies for Liquid Biopsy Analyses: A Step Towards Precision Medicine in Cancer Management
Dr Kamil Reza Khondakar, Trau Group
SERS-microfluidic assay for rapid profiling of cancer biomarkers
Dr Masih Rashidi, Martin Group
Renewable chemicals and fuel additives from lignin: an interplay of lignin structure, valorisation, and upgrading
Dr Mostafa Kamal Masud, Yamauchi Group
Nanoarchitectured Point-of-Care Detection System for Clinically Relevant Biomarkers
Dr Matthew Neil Henry, Mahler Group
Engineering Chinese hamster ovary cells for improved antibody productivity by modulating feedback regulation of the secretory pathway
Dr Nicolas Eugenio Zaragoza, Marcellin Group
Understanding toxin production in Clostridium tetani: a systems approach
Dr Nicole Monica Dawn van der Burg, PhD, Hons I, BSc, Monteiro Group
Reducing allergic airway inflammation with high-density microprojection array skin patches
Dr Wang Haofei, Zhao Group
Biomimetic chip platform for studying drug delivery systems
Dr Mu Xiao, Wang Group
Development of new photocatalysts with efficient utilization of charge carriers
Dr Arukattu Patabandige Gayathri Rukshani Ediriweera, Thurecht group
Development of Polymeric Theranostics using Bioorthogonal Chemistry
Dr Amal J Sivaram, Thurecht Group
Design and synthesis of nanomaterials as combination therapeutics
Dr Rebecca Lane, Trau Group
Extracellular Vesicles as Circulating Breast Cancer Biomarkers
Dr Harish Padmanabhan, Cooper-White Group
In vitro optimization of osteogenic differentiation outcomes from human mesenchymal stem cells
Dr Waqas Aslam, Wang Group
Value-adding to stranded carbon resources via catalytic conversion of syngas into oxygenated fuels
Dr Yanheng Wu, Xu Group
Developing inorganic nanoplatforms for efficient siRNA delivery to improve cancer immunotherapy
Dr Yilun Wu, Xu Group
Developing lipid-coated calcium carbonate/phosphate hybrid nanoparticles as a gene/drug co-delivery platform for combined cancer therapy
Dr Yun Liu, Zhao Group
Polymeric Nanoparticles for Drug Delivery
Dr Zhengying Gu, Yu Group
Engineered iron-based nanomaterials for macrophage-centred anti-cancer application
